Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells

Alterations of the EGFR/ERK and Hippo/YAP pathway have been found in non-small cell lung cancer (NSCLC). Herein, we show that ERK1 and ERK2 have an effect on the Hippo/YAP pathway in human NSCLC cells. Firstly, inhibition of ERK1/2 by siRNA or small-molecular inhibitors decreased the YAP protein lev...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Bin, Yang, Yi-Lin, Xu, Zhidong, Dai, Yuyuan, Liu, Shu, Mao, Jian-Hua, Tetsu, Osamu, Li, Hui, Jablons, David M., You, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414195/
https://www.ncbi.nlm.nih.gov/pubmed/25738359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414195/
https://www.ncbi.nlm.nih.gov/pubmed/25738359

Ejemplares similares